Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q1 FY2020 Earnings Presentation
12 slides from Phibro Animal Health's earnings presentation, Nov 5, 2019
Slide 1: Phibro Animal Health Corporation
Phibro Animal Health Corporation First Quarter – September 30, 2019 U.S. toll-free +1-866-211-3051 Webcast and Conference Call International toll +1-647-689-6616 November 5, 2019 Conference ID: 9196206
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements d
Slide 3: GAAP and Non-GAAP Financial Information
GAAP and Non-GAAP Financial Information Reported results are presented in accordance with GAAP Adjusted results are GAAP results adjusted to exclude - Acquisition-related items, including intangible amortization, cost of goods sold, accrued compensation costs, transaction costs and accrued interest
Slide 4: Opening Remarks and Financial Review
Opening Remarks and Financial Review Jack Bendheim Chairman, President, Chief Executive Officer Richard Johnson Chief Financial Officer 4 November 5, 2019 Webcast and Conference Call
Slide 5: Highlights
Highlights Q1 – September 2019 Net sales decreased due to reduced volumes in Consolidated Animal Health and lower average selling prices in Mineral Nutrition, partially offset by growth in For the three months ended Performance Products. Animal Health sales 2019 2018 Change September 30 declined due
Slide 6: Selected Line Items
Selected Line Items Q1 – September 2019 Consolidated Adjusted gross profit For the three months ended September 30 2019 2018 Change - Animal Health volume declines and unfavorable (in millions, except per share amounts and percentages) product mix in MFAs and other and vaccines, partially offset by
Slide 7: Animal Health
Animal Health Q1 – September 2019 MFAs and other Animal Health - Lower demand in China due to ASF For the three months ended - Unfavorable customer order patterns in other 2019 2018 Change international regions September 30 (in millions, except percentages) Nutritional specialties - Volume growth in
Slide 8: Other Segments
Other Segments Q1 – September 2019 For the three months ended 2019 2018 Change September 30 (in millions, except percentages) Mineral Nutrition Mineral Nutrition - Sales decreased due to lower average Net sales $ 52.6 $ 54.8 $ (2.2) (4)% selling prices; volumes increased Adjusted EBITDA $ 3.5 $ 2.6
Slide 9: Capitalization
Capitalization September 30, 2019 3.7x leverage ratio at September 30, 2019 - $396 million total debt - $108 million Adjusted EBITDA $79 million cash and short-term investments on hand at September 30, 2019 $66 million use of cash before financing for the September 2019 quarter, including $55 millio
Slide 10: Guidance
Guidance Year – June 2020 FY2020 FY2019 Change low high low high (in millions, except per share amounts and percentages) Net s ales - Anim al Health s egm ent $ 537 - $ 557 $ 532 1% - 5% Net s ales 833 - 863 828 1% - 4% Adjus ted EBITDA $ 103 - $ 107 $ 118 (13)% - (9)% Adjus ted diluted EPS $ 1.08 -
Slide 11: Q&A Session
Q&A Session 11 November 5, 2019 Webcast and Conference Call
Slide 12: © 2019 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2019 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that
Phibro Animal Health — Q1 FY2020 Earnings Presentation on 6ix